APOE and early-onset autosomal dominant Alzheimer disease: Clinically, the APOE4 gene polymorphism is associated with unfavorable outcomes following TBI [12], with the presence of at least one E4 allele associated with increased mortality [13], prolonged coma [14], poor prognosis [15], and an enhanced risk of late-onset Alzheimer’s disease [16].